null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Disease Control Priorities, Third Edition (Volume 4) (Mental, Neurological, and Substance Use Disorders)

List Price: $35.00
SKU:
9781464804267
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Vikram Patel, Dan Chisholm, Tarun Dua, Ramanan Laxminarayan, Mari'a Lena Medina-Mora
    Format:
    Paperback
    Pages:
    304
    Publisher:
    The World Bank (March 10, 2016)
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9781464804267
    ISBN-10:
    1464804265
    Dimensions:
    8.5" x 11" x 0.7"
    File:
    Eloquence-IPG_03192026_P9854863_onix30_Complete-20260319.xml
    Folder:
    Eloquence
    List Price:
    $35.00
    Series:
    Disease Control Priorities
    As low as:
    $33.25
    Publisher Identifier:
    P-IPG
    Discount Code:
    H
    Weight:
    30.72oz
    Pub Discount:
    32
    Imprint:
    World Bank Publications
  • Overview

    Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.